Showing results (171-180 of 224) with videos related to
Sort By:
Pageof 23
JAMA Dermatology|December 1, 2017
Sensitivity of Preference-Based Quality-of-Life Measures for Economic Evaluations in Early-Stage MelanomaMbathio Dieng, Nadine A Kasparian, Anne E Cust, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 21, 2011
Effect of medical Qigong on cognitive function, quality of life, and a biomarker of inflammation in cancer patients: a randomized controlled trialByeongsang Oh, Phyllis N Butow, Barbara A Mullan, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 22, 2008
Does age really matter? Recall of information presented to newly referred patients with cancerJesse Jansen, Phyllis N Butow, Julia C M van Weert, et al.Familial Cancer|May 10, 2021
Pilot study of an online training program to increase genetic literacy and communication skills in oncology healthcare professionals discussing BRCA1/2 genetic testing with breast and ovarian cancer patientsBettina Meiser, Paula Woodward, Margaret Gleeson, et al.Applied Health Economics and Health Policy|June 23, 2019
Cost-Effectiveness of a Psycho-Educational Intervention Targeting Fear of Cancer Recurrence in People Treated for Early-Stage MelanomaMbathio Dieng, Nikita Khanna, Nadine A Kasparian, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2009
To tell or not to tell: the community wants to know about expensive anticancer drugs as a potential treatment optionLinda Mileshkin, Penelope E Schofield, Michael Jefford, et al.Patient Education and Counseling|September 17, 2011
Patient perspectives regarding communication about prognosis and end-of-life issues: how can it be optimised?Adam Walczak, Phyllis N Butow, Patricia M Davidson, et al.Psycho-Oncology|July 21, 2006
Psychosocial factors and patients' preferences for adjuvant chemotherapy in early breast cancerVlatka M Duric, Phyllis N Butow, Louise Sharpe, et al.The Medical Journal of Australia|August 24, 2018
Cancer Molecular Screening and Therapeutics (MoST): a framework for multiple, parallel signal-seeking studies of targeted therapies for rare and neglected cancersSubotheni Thavaneswaran, Lucille Sebastian, Mandy Ballinger, et al.Palliative Medicine|August 9, 2022
Palliative paramedicine: Comparing clinical practice through guideline quality appraisal and qualitative content analysisMadeleine L Juhrmann, Natalie E Anderson, Mark Boughey, et al.Pageof 23